The objective of the present study was to develop simple fast disintegrating tablets of Rosiglitazone for improving patient compliance, especially paediatric and geriatric categories by effervescent method. Croscarmellose sodium was used as superdisintigrant along with blend of sodium bicarbonate, anhydrous citric acid and tartaric acid in different ratios as effervescent material and directly compressible mannitol to enhance mouth feel. The prepared batches of tablets were evaluated for weight variation, hardness, friability, drug content uniformity, in-vitro dispersion time. The tablet formulation containing 10% w/w of Crospovidone, 20% w/w sodium bicarbonate, 15%w/w citric acid and 20%w/w of MCC emerged as the overall best formulation (with an in vitro dispersion time of approximately 13s, t50% = 1.24 min and t70% = 1.65 min), based on the in-vitro drug release characteristics, compared to commercial conventional tablet formulation (which shows 118s, 13.75 min and 22.25 min respectively). Infrared spectroscopic studies revealed no drug–excipient interactions. Short-term stability studies conducted at 40 ±2°C/75±5%RH on the best formulation indicated that there were no significant changes in drug content and in-vitro dispersion time (p<0.05). The present study clearly demonstrates that fast dissolving tablets of Rosiglitazone could be successfully prepared by direct compression method in a cost effective manner.
Loading....